Paramita Mukherjee

Title: Paramita Mukherjee: Innovator in ITK Inhibitors

Introduction

Paramita Mukherjee is a distinguished inventor based in Carbondale, IL (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of ITK inhibitors. With a total of 4 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents, Mukherjee has developed pyrrolopyrimidine ITK inhibitors. These patents disclose arylpyridinone compounds and compositions that are useful in treating ITK-mediated diseases, such as inflammation. The structures of these compounds are detailed in Formulas (I)-(IV), where the R groups, m, n, and X are defined in the comprehensive description. Additionally, methods for inhibiting ITK activity in human or animal subjects are also provided.

Career Highlights

Throughout her career, Paramita Mukherjee has worked with notable companies, including Aclaris Therapeutics, Inc. and Adaris Therapeutics, Inc. Her innovative research has positioned her as a key figure in the pharmaceutical industry, particularly in the realm of targeted therapies.

Collaborations

Mukherjee has collaborated with esteemed colleagues such as Eric Jon Jacobsen and David R Anderson. These partnerships have further enhanced her research and development efforts in the field of ITK inhibitors.

Conclusion

Paramita Mukherjee's contributions to the field of medicinal chemistry and her innovative patents in ITK inhibitors highlight her as a leading inventor. Her work continues to pave the way for advancements in the treatment of inflammatory diseases.